Cannabix Technologies Provides Update on Marijuana Breathalyzer Development
April 17 2019 - 8:40AM
Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the
“Company or Cannabix”) developer of the Cannabix Marijuana
Breathalyzer for law enforcement and the workplace, is pleased to
report that recent characterization work with Cannabix’s FAIMS
(field asymmetric waveform ion mobility spectrometry) THC detection
device with human subjects has shown the ability to consistently
discriminate unwanted ions from complex human breath background
matrices allowing for THC (∆9-tetrahydrocannabinol)
detection. In particular, recent testing with updated FAIMS
cell geometries has shown the ability to consistently supress
several compounds that are commonly found in breath like nicotine,
garlic, onion, meats, ethanol, and volatile flavorants such as
methyl salicylate and menthol (commonly found in gum) allowing for
discrimination and mobility of THC in exhaled breath.
The Company is also pleased to report that engineers have
developed a new atmospheric pressure chemical ionization source
that provides significantly improved ion control in terms of
intensity, stability, and focusing. Early testing with high
concentrations of a range of interferents collected from the breath
of human subjects did not affect the sensitivity of the FAIMS
device. These include complex matrices such as tomato juice and
mouthwash. Testing with various common high salt and high sugar
content electrolyte drinks was also conducted to determine if
adduct ions would form that could interfere with the device, thus
far none of these have done so.
Cannabix scientists have been focusing their efforts to complete
characterization of FAIMS with various possible breath and
environmental contaminants and are nearing completion of this phase
of development. The Company then plans to initiate third-party
testing and piloting of the device. The Company has received
interest in piloting from both U.S. and Canadian law enforcement
groups as well as other organizations that drug test their
employees.
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is a leader in marijuana breathalyzer
development for law enforcement and the workplace. Cannabix has
established breath testing technologies in the pursuit of bringing
durable, portable hand-held tools to market to enhance detection of
marijuana impaired driving offences on roads at a time when
marijuana is becoming legal in many global jurisdictions. Cannabix
is working to develop drug-testing devices that will detect THC-
the psychoactive component of marijuana that causes intoxication-
using breath samples. In particular, Cannabix is focused on
developing breath testing devices for detection of recent use of
THC, in contrast to urine testing for THC metabolite that requires
an invasive collection and reflects previous usage from days or
even weeks earlier. The devices will also be useful for other
practical applications such as testing employees in the workplace
where impairment by THC can be hazardous.
We seek Safe Harbor.
On behalf of the Board of Directors
“Rav Mlait”
CEOCannabix Technologies Inc.
For further information, contact the Company at
info@cannabixtechnologies.com
The CSE has not reviewed and does not accept responsibility for
the adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking Statements This
press release contains forward-looking information that involves
various risks and uncertainties regarding future events. Such
forward-looking information can include without limitation
statements based on current expectations involving a number of
risks and uncertainties and are not guarantees of future
performance of the Company, such as final development of a
commercial or prototype product(s), successful trial or pilot of
company technologies, no assurance that commercial sales of any
kind actually materialize; no assurance the Company will have
sufficient funds to complete product development. There are
numerous risks and uncertainties that could cause actual results
and the Company’s plans and objectives to differ materially from
those expressed in the forward-looking information, including: (i)
adverse market conditions; (ii) risks regarding protection of
proprietary technology; (iii) the ability of the Company to
complete financings; (iv) the ability of the Company to develop and
market its future product; and (v) risks regarding government
regulation, managing and maintaining growth, the effect of adverse
publicity, litigation, competition and other factors which may be
identified from time to time in the Company's public announcements
and filings. There is no assurance that the marijuana breathalyzer
business will provide any benefit to the Company, and no assurance
that any proposed new products will be built or proceed. There is
no assurance that existing “patent pending” technologies licensed
by the Company will receive patent status by regulatory
authorities. The Company is not currently selling commercial
breathalyzers. Actual results and future events could differ
materially from those anticipated in such information. These and
all subsequent written and oral forward-looking information are
based on estimates and opinions of management on the dates they are
made and are expressly qualified in their entirety by this notice.
Except as required by law, the Company does not intend to update
these forward-looking statements.
Cannabix Technologies (CSE:BLO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cannabix Technologies (CSE:BLO)
Historical Stock Chart
From Sep 2023 to Sep 2024